WeedMD Announces Delayed Filing of its 2020 Annual Financial Disclosure
WeedMD announced today that the filing of its audited annual financial statements, management's discussion and analysis, and related CEO...
21
Apr 2021
0
WeedMD.com
19
Apr 2021
WeedMD Announces Participation in Upcoming Investor Events
WeedMD is pleased to announce that George Scorsis, WeedMD’s CEO and Executive Chair, is scheduled to participate in the following upcoming investor events...
14
Apr 2021
WeedMD Appoints Dynamic Leader Beth Carreon as New Chief Financial Officer
Formerly of Tilray Canada and Nestlé Canada, brings over 20 years of corporate finance, banking, M&A, and CPG experience...
30
Mar 2021
WeedMD Added to Horizons Marijuana Life Sciences Index ETF
WeedMD is pleased to announce the Company has been added to the Horizons Marijuana Life Sciences Index ETF following HMMJ’s quarterly rebalancing...
29
Mar 2021
WeedMD Announces Supplemental Listing of Warrants
WeedMD announced today that the TSX Venture Exchange has accepted for listing 19,046,875 common share purchase warrants of the Company issued in...
25
Mar 2021
WeedMD’s Color Cannabis Expands Product Portfolio with Debut of Live Resin in Pedro’s Sweet Sativa Cultivar
Company partners with Ontario’s Peak Processing to produce high-margin specialty products using terpene-rich biomass, with live resin available for sale in Ontario commencing in May, 2021...
24
Mar 2021
From Plant to Pouch: Our Processes Carry Weight, From Cultivation to Post-Harvest Care
From nitrogen-flushed packaging to preserving trichomes with Boveda Terpene Shields™, learn more about our approach to growing, preserving and protecting our favourite flowers...
12
Mar 2021
WeedMD Announces Closing of $17.25 Million Bought Deal Offering
WeedMD s pleased to confirm it has closed its previously announced bought deal short-form prospectus offering of 35,937,500 units (“Units”) at a price...
02
Mar 2021
WeedMD Inc. Announces Amendment of Bought Deal Equity Financing
WeedMD announced today that, further to its press release dated February 11, 2021 announcing a $17.5 million bought deal financing, the Company has...
26
Feb 2021
WeedMD Files Amended Third Quarter 2020 Interim Financial Statements
WeedMD announced today that it has amended and re-filed its unaudited reviewed interim financial statements for the three and nine months ended September 30, 2020...
